| Michelle Rae Carlson Smith, MD | |
|
1010 10th St, Hood River, OR 97031-1565 | |
| (541) 386-9540 | |
| (541) 386-9540 |
| Full Name | Michelle Rae Carlson Smith |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Experience | 30 Years |
| Location | 1010 10th St, Hood River, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346397262 | NPI | - | NPPES |
| 085498 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | MD20293 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Hood River Memorial Hospital | Hood river, OR | Hospital |
| Mid-columbia Medical Center | The dalles, OR | Hospital |
| Skyline Hospital | White salmon, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Columbia Pain Management, Inc. | 2062595796 | 10 |
News Archive
A promising study out today in the prestigious Journal of Neurosciences showed that in a mouse model of Rett syndrome, researchers were able to reverse abnormalities in brain activity and improve neurological function by treating the animals with an FDA-approved anesthesia drug, ketamine.
The incidence of cervical cancer in women in their 20s has risen by over 40 per cent between 1992 and 2006 in England, despite the overall incidence of cervical cancer dropping by 30 per cent, according to research that will be presented at the annual National Cancer Research Institute (NCRI) Cancer Conference in Liverpool which starts tomorrow.
Exelixis, Inc. today announced that it has regained full rights to develop and commercialize XL184. Exelixis and Bristol-Myers Squibb Company entered into a global development collaboration for XL184, the clinically most advanced MET inhibitor, in December 2008. Under the agreement, BMS and Exelixis had originally agreed to certain clinical development plans, and Exelixis maintained key rights regarding timing and funding of current and future clinical trials.
Statistical models are playing an increasingly important role in risk analysis and helping the United States and other countries around the globe mitigate the effects of natural and man-made disasters, said Siddhartha (Sid) Dalal during a presentation at the 2015 Joint Statistical Meetings (JSM 2015) yesterday in Seattle.
New technology enhancements from Varian Medical Systems, designed to make radiotherapy and radiosurgery treatments faster, more accurate, and easier to plan and deliver, will be on display at the annual meeting of the American Society for Radiation Oncology (ASTRO) in Chicago next week.
› Verified 8 days ago
| Entity Name | Columbia Pain Management, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477670172 PECOS PAC ID: 2062595796 Enrollment ID: O20080218000727 |
News Archive
A promising study out today in the prestigious Journal of Neurosciences showed that in a mouse model of Rett syndrome, researchers were able to reverse abnormalities in brain activity and improve neurological function by treating the animals with an FDA-approved anesthesia drug, ketamine.
The incidence of cervical cancer in women in their 20s has risen by over 40 per cent between 1992 and 2006 in England, despite the overall incidence of cervical cancer dropping by 30 per cent, according to research that will be presented at the annual National Cancer Research Institute (NCRI) Cancer Conference in Liverpool which starts tomorrow.
Exelixis, Inc. today announced that it has regained full rights to develop and commercialize XL184. Exelixis and Bristol-Myers Squibb Company entered into a global development collaboration for XL184, the clinically most advanced MET inhibitor, in December 2008. Under the agreement, BMS and Exelixis had originally agreed to certain clinical development plans, and Exelixis maintained key rights regarding timing and funding of current and future clinical trials.
Statistical models are playing an increasingly important role in risk analysis and helping the United States and other countries around the globe mitigate the effects of natural and man-made disasters, said Siddhartha (Sid) Dalal during a presentation at the 2015 Joint Statistical Meetings (JSM 2015) yesterday in Seattle.
New technology enhancements from Varian Medical Systems, designed to make radiotherapy and radiosurgery treatments faster, more accurate, and easier to plan and deliver, will be on display at the annual meeting of the American Society for Radiation Oncology (ASTRO) in Chicago next week.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Rae Carlson Smith, MD 2149 Cascade Ave Ste 106a, Hood River, OR 97031-1087 Ph: (541) 386-9500 | Michelle Rae Carlson Smith, MD 1010 10th St, Hood River, OR 97031-1565 Ph: (541) 386-9540 |
News Archive
A promising study out today in the prestigious Journal of Neurosciences showed that in a mouse model of Rett syndrome, researchers were able to reverse abnormalities in brain activity and improve neurological function by treating the animals with an FDA-approved anesthesia drug, ketamine.
The incidence of cervical cancer in women in their 20s has risen by over 40 per cent between 1992 and 2006 in England, despite the overall incidence of cervical cancer dropping by 30 per cent, according to research that will be presented at the annual National Cancer Research Institute (NCRI) Cancer Conference in Liverpool which starts tomorrow.
Exelixis, Inc. today announced that it has regained full rights to develop and commercialize XL184. Exelixis and Bristol-Myers Squibb Company entered into a global development collaboration for XL184, the clinically most advanced MET inhibitor, in December 2008. Under the agreement, BMS and Exelixis had originally agreed to certain clinical development plans, and Exelixis maintained key rights regarding timing and funding of current and future clinical trials.
Statistical models are playing an increasingly important role in risk analysis and helping the United States and other countries around the globe mitigate the effects of natural and man-made disasters, said Siddhartha (Sid) Dalal during a presentation at the 2015 Joint Statistical Meetings (JSM 2015) yesterday in Seattle.
New technology enhancements from Varian Medical Systems, designed to make radiotherapy and radiosurgery treatments faster, more accurate, and easier to plan and deliver, will be on display at the annual meeting of the American Society for Radiation Oncology (ASTRO) in Chicago next week.
› Verified 8 days ago
David P Russo, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1010 10th St, Hood River, OR 97031 Phone: 541-386-9500 Fax: 541-386-9540 | |
Mr. Trey Rigert, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1010 10th St, Hood River, OR 97031 Phone: 541-386-9500 | |
Tracy Marie Woodson, MSPT, DPT Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1627 Woods Ct, Hood River, OR 97031 Phone: 541-386-9511 |